logo
Bioanalysis of biotherapeutics at a crossroad
One size does not fit all
MS-based approaches for studying the pharmacokinetics of protein drugs
A novel single-sensor multiplexed marker assay: a step towards simplified disease management and detection?
Bioanalytical quantification of therapeutic antibodies and the implications on drug development
Solution ELISA: platform of choice to support clinical trials for a humanized therapeutic antibody
Pfizer to close Sandwich site in R&D overhaul
QPS accesses additional clinical and bioanalytical capabilities by partnership with India’s Bioserve
Book Review: Monolithic Chromatography and its Modern Applications
Paradigm of combination biologics: analytical challenges related to pharmacokinetic assays and interpretation of pharmacokinetic and immunogenicity results
Dual ligation hybridization assay for the specific determination of oligonucleotide therapeutics
Unique challenges of providing bioanalytical support for biological therapeutic pharmacokinetic programs
Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents
Recommendations and requirements for the design of bioanalytical testing used in comparability studies for biosimilar drug development
Bioanalytical LC–MS of therapeutic oligonucleotides
Acknowledgements